Bank Julius Baer & Co
LOGC

Bank Julius Baer & Co’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History

Bank Julius Baer & Co’s Portfolio LOGC Stock Details LOGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-19,450
Closed -$13K – 635
2022
Q1 		$13K Buy
+19,450
New +$13K ﹤0.01% 566